Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration

Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration. We studied retinal neurodegeneration using 10 different animal models, covering all m...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 11; p. e112142
Main Authors Arango-Gonzalez, Blanca, Trifunović, Dragana, Sahaboglu, Ayse, Kranz, Katharina, Michalakis, Stylianos, Farinelli, Pietro, Koch, Susanne, Koch, Fred, Cottet, Sandra, Janssen-Bienhold, Ulrike, Dedek, Karin, Biel, Martin, Zrenner, Eberhart, Euler, Thomas, Ekström, Per, Ueffing, Marius, Paquet-Durand, François
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 13.11.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration. We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death. We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance. Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose. Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: BAG FPD. Performed the experiments: BAG DT AS KK PF FPD. Analyzed the data: BAG DT AS KK SC PF KD EZ TE MU FPD. Contributed reagents/materials/analysis tools: BAG SM SK FK SC UJB KD MB TE PE FPD. Wrote the paper: BAG DT FPD.
Competing Interests: The authors declare that they have no conflict of interest.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0112142